Roflumilast Foam Effective for Seborrheic Dermatitis Patients Inadequately Responding to Steroids

In this subgroup analysis data shown at Winter Clinical, findings indicated IGA success with topical roflumilast foam among seborrheic dermatitis patients.

Related Keywords

Hawaii ,United States ,Arcutis Biotherapeutics ,Patrick Burnett ,States Matthew Zirwas ,Matthew Zirwas ,Drug Administration ,Bexley Dermatology Research Clinic ,Central States ,Global Assessment ,Clinical Dermatology Conference ,Treatment Emergent Adverse Events ,Conference ,Winter Clinical ,Roflumilast ,Zorvye ,Arcutis ,Subgroup ,Steroids ,Seborrheic Dermatitis ,